ConvaTec Group PLC (LON:CTEC) insider Ros Rivaz purchased 4,821 shares of the stock in a transaction that occurred on Wednesday, December 6th. The stock was bought at an average cost of GBX 206 ($2.77) per share, with a total value of £9,931.26 ($13,366.43).

Ros Rivaz also recently made the following trade(s):

  • On Monday, December 4th, Ros Rivaz purchased 4,908 shares of ConvaTec Group stock. The stock was bought at an average cost of GBX 202 ($2.72) per share, with a total value of £9,914.16 ($13,343.42).

Shares of ConvaTec Group PLC (CTEC) traded up GBX 0.10 ($0.00) during trading hours on Wednesday, reaching GBX 207.50 ($2.79). The company’s stock had a trading volume of 5,471,117 shares, compared to its average volume of 8,360,000. ConvaTec Group PLC has a 52-week low of GBX 181.40 ($2.44) and a 52-week high of GBX 349.10 ($4.70).

A number of equities research analysts recently commented on the company. Numis Securities reissued a “reduce” rating and issued a GBX 180 ($2.42) price target on shares of ConvaTec Group in a research report on Tuesday. Deutsche Bank reissued a “sell” rating and issued a GBX 180 ($2.42) price target on shares of ConvaTec Group in a research report on Friday, December 1st. Peel Hunt reissued a “hold” rating and issued a GBX 250 ($3.36) price target on shares of ConvaTec Group in a research report on Tuesday, October 31st. lowered ConvaTec Group to a “hold” rating and lowered their price target for the company from GBX 345 ($4.64) to GBX 240 ($3.23) in a research report on Tuesday, October 17th. Finally, Credit Suisse Group lowered their price target on ConvaTec Group from GBX 280 ($3.77) to GBX 225 ($3.03) and set a “neutral” rating for the company in a research report on Tuesday, October 17th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. ConvaTec Group currently has a consensus rating of “Hold” and an average target price of GBX 251.20 ($3.38).

COPYRIGHT VIOLATION WARNING: This piece was reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/12/06/convatec-group-plc-ctec-insider-ros-rivaz-acquires-4821-shares.html.

About ConvaTec Group

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.